Form 4: Capital Bancorp Inc. Director Brannan C. Scott Reports Beneficial Ownership Changes
SEC Form 4 Filing
Director Brannan C. Scott reports changes in beneficial ownership of Capital Bancorp Inc. stock and derivative securities, including the acquisition of restricted stock units and stock options.
Summary
- On March 3, 2025, Brannan C. Scott, a director of Capital Bancorp Inc., filed a Form 4 to report changes in beneficial ownership.
- The report details the acquisition of 946 Restricted Stock Units (RSUs) that will vest on March 3, 2026, each representing the right to receive one share of common stock.
- Scott also acquired 3,500 stock options with an exercise price of $30.51, expiring on March 3, 2030.
- The report also lists existing stock options with varying exercise prices and vesting schedules.
- Scott directly owns 2,505 shares of common stock.
- Scott indirectly owns shares of common stock through UTMA accounts for four grandchildren.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document primarily reports routine transactions. The acquisition of equity may be viewed positively, but it's a standard practice.
Positives
- The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
- The vesting schedules of the stock options incentivize long-term commitment from the director.
Industry Context
Form 4 filings are standard practice and provide transparency regarding the holdings and transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Comparison to Industry Standards
- Director equity grants are a common practice in the banking industry to align management incentives with shareholder value.
- The vesting schedules and exercise prices of the stock options are typical for executive compensation packages in similar-sized financial institutions.
- Comparing the size of the equity grants to those of directors at peer banks like Eagle Bancorp or Sandy Spring Bancorp would provide further context.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding the director's stake in the company.
- The equity grants align the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/31/2021 | Grant date for stock options with an exercise price of $13.89. |
| 12/31/2022 | Grant date for stock options with an exercise price of $26.41. |
| 01/01/2024 | Grant date for stock options with an exercise price of $23.54. |
| 01/01/2025 | Grant date for stock options with an exercise price of $24.20. |
| 03/03/2025 | Date of the reported transaction and grant date for new RSUs and stock options. |
| 12/31/2025 | Expiration date for stock options with an exercise price of $13.89. |
| 03/03/2026 | Vesting date for the acquired Restricted Stock Units. |
| 12/31/2026 | Expiration date for stock options with an exercise price of $26.41. |
| 01/01/2028 | Expiration date for stock options with an exercise price of $23.54. |
| 01/01/2029 | Expiration date for stock options with an exercise price of $24.20. |
| 03/03/2030 | Expiration date for the newly acquired stock options with an exercise price of $30.51. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.